|
TCERG1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.09089999999579E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.846400E-04 |
| Normal-vs-Stage2 |
1.037640E-01 |
| Normal-vs-Stage3 |
1.949870E-02 |
| Normal-vs-Stage4 |
1.572200E-01 |
| Stage1-vs-Stage2 |
7.968000E-01 |
| Stage1-vs-Stage3 |
8.776600E-01 |
| Stage1-vs-Stage4 |
3.793400E-01 |
| Stage2-vs-Stage3 |
8.794800E-01 |
| Stage2-vs-Stage4 |
4.641600E-01 |
| Stage3-vs-Stage4 |
4.086200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.96599999999459E-05 |
| Normal-vs-AfricanAmerican |
5.484500E-03 |
| Normal-vs-Asian |
1.882600E-03 |
| Caucasian-vs-AfricanAmerican |
9.599800E-01 |
| Caucasian-vs-Asian |
4.154800E-01 |
| AfricanAmerican-vs-Asian |
4.258800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.375990E-04 |
| Normal-vs-Female |
9.98930000000176E-05 |
| Male-vs-Female |
3.167600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.142000E-02 |
| Normal-vs-Extreme_Weight |
2.263900E-03 |
| Normal-vs-Obese |
1.120510E-03 |
| Normal-vs-Extreme_Obese |
3.861600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.758400E-01 |
| Normal_Weight-vs-Obese |
9.091800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.714220E-01 |
| Extreme_Weight-vs-Obese |
5.095600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.675200E-01 |
| Obese-vs-Extreme_Obese |
2.598400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.27079999999269E-05 |
| Normal-vs-Age(41-60Yrs) |
9.48319999971581E-07 |
| Normal-vs-Age(61-80Yrs) |
8.260600E-03 |
| Normal-vs-Age(81-100Yrs) |
8.398800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.839200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.509500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.836000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.722200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.329700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.079000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.7042299999992E-05 |
| Normal-VS-Type2 PRCC |
1.707970E-01 |
| Normal-VS-KIRP CIMP |
1.484170E-03 |
| Normal-VS-Unclassified PRCC |
4.720800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.793600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.486800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.242000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.634400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.991630E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.065800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.240840E-01 |
| Normal-vs-N1 |
7.877600E-03 |
| Normal-vs-N2 |
3.956300E-02 |
| N0-vs-N1 |
3.058500E-02 |
| N0-vs-N2 |
2.782200E-01 |
| N1-vs-N2 |
6.164400E-01 |
|
|
